Abstract COVID‐19, caused by SARS‐CoV‐2 infection, continues to be a major public
health crisis around the globe. Development of vaccines and the first cluster of antiviral …

The SARS-CoV-2 outbreak and pandemic that began near the end of 2019 has posed a
challenge to global health. At present, many candidate small-molecule therapeutics have …

Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …

The COVID‐19 pandemic remains a major health concern worldwide, and SARS‐CoV‐2 is
continuously evolving. There is an urgent need to identify new antiviral drugs and develop …

SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as
Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been …

The COVID-19 pandemic poses a fundamental challenge to global health. Since the
outbreak of SARS-CoV-2, great efforts have been made to identify antiviral strategies and …

During the first year of the outbreak of the COVID-19 pandemic, many drugs and drug
candidates have been evaluated as treatment options. None yet has proved to be an …

The outbreak of coronavirus disease 2019 (COVID‐19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a global crisis. As …

The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

The coronavirus disease-2019 (COVID-19) pandemic continues to challenge health care
systems around the world. Scientists and pharmaceutical companies have promptly …